Literature DB >> 914527

Test sequences in screening for breast cancer.

T O Siu, J R Hancock.   

Abstract

Published data of Stark and Way on the screening of 2,684 women at high risk of breast cancer are analyzed to arrive at a preferred sequence of screening tests. In the practical situation where palpation first signals a problem, the analysis suggests thermography to follow. Women with positive thermograms should then be biopsied, and those with negative thermograms should be mammographed. A positive mammogram calls for biopsy, and a negative one calls for close follow-up. For high-risk women whose breasts appear normal on palpation, a subsequent negative thermogram is not definitive enough to terminate investigation, but a negative mammogram after a negative palpation is enough evidence to waive further investigation for some time. A positive mammogram calls for immediate biopsy in any circumstance.

Entities:  

Mesh:

Year:  1977        PMID: 914527      PMCID: PMC1071995     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  6 in total

1.  Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests.

Authors:  A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

2.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

3.  Lead time in breast cancer detection and implications for periodicity of screening.

Authors:  S Shapiro; J D Goldberg; G B Hutchison
Journal:  Am J Epidemiol       Date:  1974-11       Impact factor: 4.897

4.  The screening of well women for the early detection of breast cancer using clinical examination with thermography and mammography.

Authors:  A M Stark; S Way
Journal:  Cancer       Date:  1974-06       Impact factor: 6.860

5.  Lead time gained by diagnostic screening for breast cancer.

Authors:  G B Hutchison; S Shapiro
Journal:  J Natl Cancer Inst       Date:  1968-09       Impact factor: 13.506

6.  Periodic breast cancer screening. The first two years of screening.

Authors:  S Shapiro; P Strax; L Venet
Journal:  Arch Environ Health       Date:  1967-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.